Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study

被引:10
作者
Xu, Haitao [1 ]
Zhang, Lianguo [1 ]
Miao, Jing [2 ]
Liu, Shuai [1 ]
Liu, Hongjian [1 ]
Jia, Teng [1 ]
Zhang, Qingguang [1 ]
机构
[1] Binzhou Med Univ Hosp, Dept Thorac Surg, 661 Huanghe 2nd Rd, Binzhou 256603, Shandong, Peoples R China
[2] Binzhou Peoples Hosp, Dept Neonatal Intens Care Unit, 515 Huanghe 7th Rd, Binzhou 256603, Shandong, Peoples R China
关键词
Adenocarcinoma of the esophagogastric junction; Recurrence; Surgery; Chemotherapy; prognosis; SQUAMOUS-CELL CARCINOMA; NEOADJUVANT CHEMORADIOTHERAPY; CURATIVE RESECTION; CHEMOTHERAPY; SURGERY; ESOPHAGEAL; THERAPY; IMPACT;
D O I
10.1186/s12957-020-01917-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The prognosis of adenocarcinoma of the esophagogastric junction (AEG) is poor. Understanding the postoperative recurrence pattern of AEG is helpful to verify the effectiveness of treatment and optimize subsequent treatment, so as to improve prognosis. Methods This single-center retrospective study included patients with stage III AEG who underwent surgical treatment between January 2009 and December 2016. According to the different postoperative treatment arm, patients were divided into surgery and surgery plus chemotherapy groups. Recurrence-free survival was used as the outcome to compare the recurrence site and pattern between the groups. Results In total, were 306 patients enrolled, 123 in the surgery group and 183 in the surgery plus chemotherapy group. During follow-up (median 17.1 months) of 24 months after surgery, 62.0% of patients had tumor recurrence. The overall recurrence rates in the surgery and surgery plus chemotherapy groups were 86.9% and 77.0%, respectively. The recurrence patterns of both groups were mainly distant metastasis. Postoperative chemotherapy reduced the incidence of hematogenous dissemination from 51.2 to 42.0%. Multivariate Cox analysis showed that the pN stage increased the risk of recurrence, while surgery plus chemotherapy reduced the risk. Conclusions Patients with AEG have a risk of hematogenous dissemination after surgery. Postoperative treatment arm and pN stage were independent risk factors in patients with AEG. Surgery plus chemotherapy can improve recurrence-free survival and reduce distant metastasis, but they do not have a beneficial role in controlling local recurrence.
引用
收藏
页数:7
相关论文
共 25 条
[1]   The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI [J].
Al-Batran, Salah-Eddin ;
Goetze, Thorsten O. ;
Mueller, Daniel W. ;
Vogel, Arndt ;
Winkler, Michael ;
Lorenzen, Sylvie ;
Novotny, Alexander ;
Pauligk, Claudia ;
Homann, Nils ;
Jungbluth, Thomas ;
Reissfelder, Christoph ;
Caca, Karel ;
Retter, Steffen ;
Horndasch, Eva ;
Gumpp, Julia ;
Bolling, Claus ;
Fuchs, Karl-Hermann ;
Blau, Wolfgang ;
Padberg, Winfried ;
Pohl, Michael ;
Wunsch, Andreas ;
Michl, Patrick ;
Mannes, Frank ;
Schwarzbach, Matthias ;
Schmalenberg, Harald ;
Hohaus, Michael ;
Scholz, Christian ;
Benckert, Christoph ;
Knorrenschild, Jorge Riera ;
Kanngiesser, Veit ;
Zander, Thomas ;
Alakus, Hakan ;
Hofheinz, Ralf-Dieter ;
Roedel, Claus ;
Shah, Manish A. ;
Sasako, Mitsuru ;
Lorenz, Dietmar ;
Izbicki, Jakob ;
Bechstein, Wolf O. ;
Lang, Hauke ;
Moenig, Stefan P. .
BMC CANCER, 2017, 17
[2]  
Al-Batran SE, 2019, LANCET
[3]   Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma [J].
Anderegg, M. C. J. ;
van der Sluis, P. C. ;
Ruurda, J. P. ;
Gisbertz, S. S. ;
Hulshof, M. C. C. M. ;
van Vulpen, M. ;
Mohammed, N. Haj ;
van Laarhoven, H. W. M. ;
Wiezer, M. J. ;
Los, M. ;
Henegouwen, M. I. van Berge ;
van Hillegersberg, R. .
ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (08) :2282-2290
[4]   Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study - JCOG9204 [J].
Ando, N ;
Iizuka, T ;
Ide, H ;
Ishida, K ;
Shinoda, M ;
Nishimaki, T ;
Takiyama, W ;
Watanabe, H ;
Isono, K ;
Aoyama, N ;
Makuuchi, H ;
Tanaka, O ;
Yamana, H ;
Ikeuchi, S ;
Kabuto, T ;
Nagai, K ;
Shimoda, Y ;
Kinjo, Y .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4592-4596
[5]   Analysis of the clinicopathological features and prognostic factors in 734 cases of Chinese Hui and Han patients with adenocarcinoma of the esophagogastric junction [J].
Cao, Jianqiao ;
Yang, Ting ;
Wang, Guanhua ;
Zhang, Hongfei ;
You, Yanjie ;
Chen, Jing ;
Yang, Jingwen ;
Yang, Wenjun .
SURGICAL ONCOLOGY-OXFORD, 2018, 27 (03) :556-562
[6]   Tumor Stage After Neoadjuvant Chemotherapy Determines Survival After Surgery for Adenocarcinoma of the Esophagus and Esophagogastric Junction [J].
Davies, Andrew R. ;
Gossage, James A. ;
Zylstra, Janine ;
Mattsson, Fredrik ;
Lagergren, Jesper ;
Maisey, Nick ;
Smyth, Elizabeth C. ;
Cunningham, David ;
Allum, William H. ;
Mason, Robert C. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :2983-+
[7]   Predictors of Timing and Patterns of Recurrence after Curative Resection for Gastric Cancer [J].
Eom, Bang Wool ;
Yoon, Hongman ;
Ryu, Keun Won ;
Lee, Jun Ho ;
Cho, Soo Jeong ;
Lee, Jong Yeul ;
Kim, Chan Gyoo ;
Choi, Il Ju ;
Lee, Jong Seok ;
Kook, Myung Cherl ;
Park, Sook Ryun ;
Nam, Byung-Ho ;
Kim, Young-Woo .
DIGESTIVE SURGERY, 2010, 27 (06) :481-486
[8]   Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance) [J].
Fuchs, Charles S. ;
Niedzwiecki, Donna ;
Mamon, Harvey J. ;
Tepper, Joel E. ;
Ye, Xing ;
Swanson, Richard S. ;
Enzinger, Peter C. ;
Haller, Daniel G. ;
Dragovich, Tomislav ;
Alberts, Steven R. ;
Bjarnason, Georg A. ;
Willett, Christopher G. ;
Gunderson, Leonard L. ;
Goldberg, Richard M. ;
Venook, Alan P. ;
Ilson, David ;
O'Reilly, Eileen ;
Ciombor, Kristen ;
Berg, David J. ;
Meyerhardt, Jeffrey ;
Mayer, Robert J. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (32) :3671-+
[9]   Western strategy for EGJ carcinoma [J].
Giacopuzzi, Simone ;
Bencivenga, Maria ;
Weindelmayer, Jacopo ;
Verlato, Giuseppe ;
de Manzoni, Giovanni .
GASTRIC CANCER, 2017, 20 :S60-S68
[10]   Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction [J].
Hosoda K. ;
Yamashita K. ;
Katada N. ;
Watanabe M. .
General Thoracic and Cardiovascular Surgery, 2015, 63 (10) :549-556